Stock DNA
Other Agricultural Products
CAD 8 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-2.71
107.40%
-1.12
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Dec 2024)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-25.0%
0%
-25.0%
6 Months
-50.0%
0%
-50.0%
1 Year
-62.5%
0%
-62.5%
2 Years
-70.0%
0%
-70.0%
3 Years
-92.37%
0%
-92.37%
4 Years
-96.54%
0%
-96.54%
5 Years
-91.82%
0%
-91.82%
PharmaCielo Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
29.84%
EBIT Growth (5y)
13.20%
EBIT to Interest (avg)
-16.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.71
Sales to Capital Employed (avg)
0.18
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.20%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.12
EV to EBIT
-6.26
EV to EBITDA
-8.63
EV to Capital Employed
2.24
EV to Sales
8.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-35.81%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ
Dec'24
Sep'24
Change(%)
Net Sales
1.10
1.30
-15.38%
Operating Profit (PBDIT) excl Other Income
-0.20
-0.60
66.67%
Interest
0.80
1.00
-20.00%
Exceptional Items
-0.10
-0.90
88.89%
Consolidate Net Profit
-1.50
-2.60
42.31%
Operating Profit Margin (Excl OI)
-418.30%
-635.00%
21.67%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2024 is -15.38% vs 62.50% in Sep 2024
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2024 is 42.31% vs 0.00% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
3.50
1.50
133.33%
Operating Profit (PBDIT) excl Other Income
-3.30
-9.10
63.74%
Interest
3.40
2.90
17.24%
Exceptional Items
-1.10
-3.30
66.67%
Consolidate Net Profit
-9.10
-16.30
44.17%
Operating Profit Margin (Excl OI)
-1,323.30%
-6,846.90%
552.36%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 133.33% vs -71.70% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 44.17% vs -12.41% in Dec 2023
About PharmaCielo Ltd. 
PharmaCielo Ltd.
Other Agricultural Products
Pharmacielo Ltd, formerly AAJ Capital 1 Corp, is a Canada-based company that is engaged in the alternative medicine sector. The Company produces cannabis oils. It offers medicinal-grade oil extracts and related products, which provide relief and wellness formulas for patients in need, including those requiring higher levels of tetrahydrocannabinol (THC). The Company's wholly-owned subsidiary is PharmaCielo Colombia Holdings SAS based in Colombia. The Company works together with Cooperativa Caucannabis and more than 60 local regional farmer members in Cauca, Colombia to cultivate cannabis for the production of standardized, medicinal-grade oil extracts and related products. Pharmacielo Ltd holds Colombian licenses for cannabis.
Company Coordinates 
Company Details
82 Richmond St E , TORONTO ON : M5C 1P1
Registrar Details






